This month, Incubate executive director John Stanford's conversation with Senator Thom Tillis (R-NC) on the Making Medicine Podcast  was featured in RealClearHealth , IAM Media , and IP Watchdog . Sen. Tillis called for aggressive measures to counter China's growing economic influence, particularly in life sciences innovation, highlighting the need to pass the Patent Eligibility Restoration Act to address what he described as the current law's chilling effect on innovation: "

Incubate executive director John Stanford was featured in a BioSpace  article by news editor Dan Samorodnitsky on how the ongoing federal government shutdown is affecting the Food and Drug Administration and the broader biopharmaceutical ecosystem. As the shutdown stretches on, Stanford warned that uncertainty and funding lapses are beginning to slow biotech activity and signal risk to the United States' standing as the global center for innovation. He noted that the prolonge

Incubate executive director John Stanford was recently featured in a WSJ Pro: Venture Capital  article by reporter Brian Gormley on the ORPHAN Cures Act, a provision of the recently passed One Big Beautiful Bill Act. The new law addresses a critical flaw in the Inflation Reduction Act that has unintentionally disincentivized investment in rare disease research. Stanford highlighted the role of small biotech firms in driving innovation for rare diseases and emphasized the broa

"But the IRA is changing the calculus in a meaningful — and harmful — way."

A budget-neutral fix that would extend the time before small molecule drugs are subject negotiations but increase the minimum discounts...

Read John Stanford and JF Formela's op-ed on how we can lower health costs by spending more on drugs. By JF Formela and John Stanford The...

Developing more effective treatments for patients with no other options while also keeping costs down will require a balancing act with...